Granules India Limited · NSE:GRANULES
Granules India — Q1 FY2024 Earnings Presentation
27 slides from Granules India's earnings presentation, Aug 9, 2023
Slide 1: Presentation to the Analysts/Investors cover letter
S$ GRANULES REGISTERED OFFICE GRANULES INDIA LTD., 2nd Floor, 3rd Block, My Home Hub, Madhapur, Hyderabad - 500 081, Telangana, India. Tel: +91 40 69043500, Fax: +91 40 23115145, mail@granulesindia.com, www.granulesindia.com CIN: L24110TG1991PLC012471 Date: August 09, 2023 To, National Stock Exchang
Slide 2: Granules India Limited Earnings Presentation Q1FY24
Granules India Limited Earnings Presentation Q1FY24
Slide 3: Safe harbour
Safe harbour The Presentation is to provide the general background information about the Company’s activities as at the date of the Presentation. The information contained herein is for general information purposes only and based on estimates and should not be considered as a recommendation that any
Slide 4: Key Business Updates
Key Business Updates ▪ Employed the appropriate incident response protocols for containment IT Incident Update ▪ Enhanced security measures are being implemented ▪ Restored near normalcy production ▪ Received Establishment Inspection Report (EIR) for Gagillapur Regulatory Inspection ▪ Completion of
Slide 5: Third Party Technical Feasibility Report near completion
▪ Third Party Technical Feasibility Report near completion ▪ Identified and finalized two sites at Vizag (12 Acres) and at Kakinada (100 Acres) ▪ Phase I at Vizag: Pilot DCDA plant (completion end of FY24) & PAP commercial plant (completion end of FY25) ▪ Phase II at Kakinada: Start the project work
Slide 6: Q1FY24: Y-o-Y performance highlights – P&L
Q1FY24: Y-o-Y performance highlights – P&L (In ₹ Mn) Q1 FY24 Q1 FY23 Y-o-Y Gr% Y-o-Y performance Revenues were lower primarily on account of business Revenue 9,855 10,196 (3%) interruption due to the IT incident that happened in this quarter Value Added 5,063 5,060 VA% has improved primarily on acco
Slide 7: Q1FY24: Q-o-Q performance highlights – P&L
Q1FY24: Q-o-Q performance highlights – P&L (In ₹ Mn) Q1 FY24 Q4 FY23 Q-o-Q Gr% Q-o-Q performance Revenues were lower primarily on account of business Revenue 9,855 11,955 (18%) interruption due to the IT incident that happened in this quarter Value Added 5,063 5,720 VA% has improved primarily on acc
Slide 8: Q1FY24: Revenue split by market
Q1FY24: Revenue split by market (In ₹ Mn) Region wise share Q1 Q1 Y-o-Y Q4 Q-o-Q FY24 FY23 Gr% FY23 Gr% 61% 58% North 6,017 5,483 10% 6,962 (14%) 54% America Europe 2,405 2,292 5% 2,871 (16%) 24% 24% 22% 9% LATAM 481 933 (48%) 720 (33%) 5% 6% 5% 6% 8% 5% 6% 7% India 504 821 (39%) 680 (26%) North Eur
Slide 9: Q1FY24: Revenue split by division
Q1FY24: Revenue split by division (In ₹ Mn) Division wise share Q1 Q1 Y-o-Y Q4 Q-o-Q FY24 FY23 Gr% FY23 Gr% 55% 51% 54% API 3,000 2,341 28% 3,664 (18%) 30% 31% PFI 1,482 2,368 (37%) 2,174 (32%) 23% 23% 18% 15% FD 5,373 5,487 (2%) 6,117 (12%) API PFI FD Q1 FY24 % Q4 FY23 % Q1 FY23 % ➢ Y-o-Y growth in
Slide 10: Q1FY24: Cashflow metrics and Ratios
Q1FY24: Cashflow metrics and Ratios (In ₹ Mn) Q1 FY24 Q4 FY23 Q1 FY24 Q4 FY23 Q1 FY24 Q4 FY23 Fixed Net debt/ ROCE% 9.4% 21.1% asset turn 1.64 2.06 EBITDA 1.57x 0.84x IT incident this quarter impacted the Net debt has increased only by Rs.899 Lower asset turns are primarily on revenues which led to
Slide 11: Last 5 years performance: Sales and profitability
Last 5 years performance: Sales and profitability (In ₹ Mn) Sales: 5yr CAGR: 22% VA and VA%: 5yr CAGR: 23% 45,119 22,046 37,649 18,463 18,813 51% 32,375 47% 45% 13,177 57% 25,986 50% 49% 22,792 10,236 16,918 7,955 FY18 FY19 FY20 FY21 FY22 FY23 FY18 FY19 FY20 FY21 FY22 FY23 EBITDA and EBITDA%: 5yr CA
Slide 12: Last 5 years performance: Cashflow and ratios
Last 5 years performance: Cashflow and ratios (In ₹ Mn) ROCE% Asset turns Net debt and Net debt/EBITDA 28.6% 8,704 9,082 2.00 1.98 2.02 2.06 7,671 1.89 6,966 21.1% 1.75 2.36 6,058 5,752 19.3% 3.13 17.4% 13.1% 1.15 0.97 11.4% 0.67 0.84 FY18 FY19 FY20 FY21 FY22 FY23 FY18 FY19 FY20 FY21 FY22 FY23 FY18
Slide 13: ANDA and Dossier Filing status
ANDA and Dossier Filing status GPI IP GIL IP Filing Status South Total USA USA Europe Canada UK Others Africa Approved 24 57 5 6 - 3 1 72 Tentatively Approved 1 2 - - - - - 2 To be approved 5 12 3 1 6 - 3 25 Total Products 30 71 8 7 6 3 4 99 ANDA/Dossier filed - Therapeutic area wise Analgesics 29 C
Slide 14: Strategic Priorities and Organizational Transformation
Strategic Priorities and Organizational Transformation
Slide 15: Pursuing Purpose-led Growth
Pursuing Purpose-led Growth — Chairman & Managing Director
Slide 16: Purpose, Vision & Values
Purpose, Vision & Values PURPOSE Healing lives responsibly through pioneering green science. VISION To establish ourselves as a world leader in green chemical and pharmaceutical industry by harnessing cutting-edge technologies to enhance. quality of life. Our new VALUES 15
Slide 17: Strategic Priorities
Strategic. Priorities 16
Slide 18: Strengthening the core: Existing Manufacturing strength
Strengthening the core: Existing Manufacturing strength 17
Slide 19: Strengthening the core: Building & sustaining our competitive advantage
Strengthening the core: Building & sustaining our competitive advantage 18
Slide 20: R&D and Innovation: Expanding capabilities
R&D and Innovation: Expanding capabilities Strengthened headcount to ̴ 300 across spectrum of R&D centers with complementary capabilities Integrated Product Development Genome Valley – MN Park R&D facility for Integrated Product Development ▪ ̴ 170 scientists across API & FD R&D ▪ Fast tracking prod
Slide 21: R&D and Innovation: Becoming an innovation and science-led enterprise
R&D and Innovation: Becoming an innovation and science-led enterprise Green Score in R&D Enzyme & Bio Transformation Flow Technology Platform Development Eco friendly substitute to metallo- Excellence in identified chemistries Implementation of Green card and Eco catalysis scale initiatives. From th
Slide 22: Sustainability & Response to Climate Change
Sustainability & Response to Climate Change An area of emerging opportunities From Vision to Action Industries need to Lead the Way in Sustainable Supply Chains and Green-Tech 21
Slide 23: Our Sustainability & ESG Journey
Our Sustainability & ESG Journey 22
Slide 24: Overhead Water tanks built for over 2500 villagers
Overhead Water tanks built for over 2500 villagers 23
Slide 25: Our ESG Approach & Materiality Assessment
Important to stakeholders ——————> Our ESG Approach & Materiality Assessment In keeping with the commitment to include sustainability as one of the strategic levers, Granules conducted a detailed Materiality Assessment for the first time in the organization during FY 2023. A range of sustainability t
Slide 26: Sustainability Redefined: Innovating for a Greener Future
Sustainability Redefined: Innovating for a Greener Future * Granules CZRO is the wholly owned subsidiary of Granules 25
Slide 27: Corporate address
Mr. Puneet Varshney GM Business Finance and Head Investor Relations Email: puneet.varshney@granulesindia.com www.granulesindia.com Ms. Payal Dave payal.dave@linkintime.co.in Mr. Irfan Raeen +91 97737 78669 Irfan.raeen@linkintime.co.in www.orientcap.com 532482 GRANULES Corporate address: GRAN:IN Floo